University Hospital Tuebingen
Clinical trials sponsored by University Hospital Tuebingen, explained in plain language.
-
New drug combo may boost stem cell transplant success in hard-to-treat blood cancers
Disease control Not yet recruitingThis study tests whether adding venetoclax to the usual pre-transplant chemotherapy can safely improve survival in adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS). About 27 participants aged 18–75 will receive the enhanced conditioning before …
Phase: PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 16, 2026 12:50 UTC
-
Brain and body workout at home may slow Parkinson's dementia
Disease control Not yet recruitingThis study tests a home-based training program for people with Parkinson's disease who also have mild cognitive impairment and are at high risk for dementia. Participants will cycle on a stationary bike while doing brain games on a tablet, three times a week for 30 minutes. The g…
Phase: NA • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 15, 2026 19:04 UTC
-
Engineered immune cells take on deadly pancreatic cancer in first human trial
Disease control Not yet recruitingThis early-phase trial tests a new treatment for advanced pancreatic cancer that has not responded to standard therapies. The treatment uses a patient's own immune cells, modified in the lab to target a protein called CD318 found on cancer cells. The goal is to see if this approa…
Phase: PHASE1, PHASE2 • Sponsor: University Hospital Tuebingen • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New score may predict delirium after heart surgery
Knowledge-focused Not yet recruitingThis study will test a simple score to predict which patients may become confused (delirium) after planned heart surgery. About 100 adults will be checked before surgery using memory, orientation, and frailty tests. The goal is to identify high-risk patients early so doctors can …
Sponsor: University Hospital Tuebingen • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:09 UTC